INVO Bioscience Inc

NASDAQ:INVO  
4.00
+0.07 (+1.78%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)47.32M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.33 Million
Adjusted EPS-$0.20
See more estimates
10-Day MA$3.69
50-Day MA$3.72
200-Day MA$3.99
See more pivots

INVO Bioscience Inc Stock, NASDAQ:INVO

5582 Broadcast Court, Suite 34C, Sarasota, Florida 34240
United States of America
Phone: +1.978.878.9505
Number of Employees: 10

Description

INVO BioScience, Inc. focuses on the creation of treatment options for patients diagnosed with infertility. It offers a patented medical device that is used for infertility treatment under the name INVOcell. The company was founded by Kathleen Karloff and Claude Ranoux on January 5, 2007 and is headquartered in Sarasota, FL.